Cantor Fitzgerald对Protara Therapeutics首次覆盖评级为增持

同花顺iNews
14 Mar

同花顺美股讯 3月14日Cantor Fitzgerald评级报告首次覆盖protara therapeutics,首次评级为增持。ProTARA Therapeutics于3月5日发布2024年年报,公司截至2024年12月31日,净利润-4459.60万美元,基本每股收益-2.17美元。Protara Therapeutics, Inc.最初于2006年3月24日在特拉华州注册成立。该公司是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10